Premium
Retracted : Outcome and immune reconstitution of HBV‐specific immunity in patients with reactivation of occult HBV infection after alemtuzumab‐containing chemotherapy regimen
Author(s) -
Hui CheeKin,
Cheung Winnie W.,
Leung KarWai,
Cheng Vincent C. C.,
Tang Bone S. F.,
Li Iris W. S.,
Luk John M.,
Lee Nikki P.,
Kwong YokLam,
Au WingYan,
Yuen KwokYung,
Lau George K.,
Liang Raymond
Publication year - 2008
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.22213
Subject(s) - hbcag , medicine , hbsag , alemtuzumab , hepatitis b virus , chemotherapy , elispot , regimen , immunology , chemotherapy regimen , gastroenterology , virology , t cell , immune system , antibody , virus
Retraction: The following article from HEPATOLOGY, “Outcome and immune reconstitution of HBV‐specific immunity in patients with reactivation of occult HBV infection after alemtuzumab‐containing chemotherapy regiment” by Chee‐Kin Hui, Winnie W. Cheung, Kar‐Wai Leung, Vincent C. C. Cheng, Bone S. F. Tang, Iris W. S. Li, John M. Luk, Nikki P. Lee, Yok‐Lam Kwong, Wing‐Yan Au, Kwok‐Yung Yuen, George K. Lau, Raymond Liang, published online on 8 January 2008 on Wiley InterScience (www.wileyinterscience.com), has been retracted by agreement between the author, the journal Editor‐in‐Chief, Keith D. Lindor, and John Wiley & Sons. The article has been retracted at the suggestion of the authors due to irreparable methodological problems.